Genfit Stock

Genfit Enterprise Value

The Enterprise Value (EV) of Genfit (GNFT.PA) as of Aug 13, 2026 is 418.89 M EUR. In the previous year, Enterprise Value (EV) was 430.94 M EUR — a change of -2.79% (lower).

Enterprise Value

418.89 MEUR

YoY

-2.79%

Last updated:

Enterprise Value (EV) of Genfit is 2026 418.89 M EUR. Enterprise Value (EV) of Genfit was 2025 430.94 M EUR. It decreases by -2.79% lower compared to the previous year.
Access this data via the Eulerpool API

Genfit Stock analysis

What does Genfit do? Genfit SA is a French company specializing in the development of therapies for the treatment of liver diseases, specifically non-alcoholic steatohepatitis (NASH). The company was founded in 1999 and is headquartered in Loos, France. Genfit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genfit stock

Enterprise Value (EV) of Genfit is 418.89 M EUR in 2026.

Enterprise Value (EV) of Genfit changed from 430.94 M EUR to 418.89 M EUR, representing a -2.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Genfit since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s EUR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' EUR varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Genfit with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Genfit

All Key Metrics — Genfit